UroGen Pharma (URGN) Short-term Investments (2016 - 2026)
UroGen Pharma's Short-term Investments came in at $28.84 million for Q2 2026, down 55.0% from $64.05 million a year earlier and down 4.8% from the prior quarter.
Powered by 
Analysis
UroGen Pharma (URGN) Short-term Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, UroGen Pharma's Short-term Investments was $9.71 million, down 85.0% from FY2024.
- Short-term Investments carries a five-year compound annual growth rate of -27.7% (FY2020 to FY2025).
- Going back by year, Short-term Investments was $64.7 million in FY2024 (+54.2%), $41.97 million in FY2023 (-5.8%), $44.56 million in FY2022 (-0.5%) and $44.78 million in FY2021 (-8.9%).
- The five-year range for quarterly Short-term Investments is $9.71 million (Q4 2025) to $124.66 million (Q3 2024).
- Year-over-year, Short-term Investments has declined for four consecutive quarters, with growth averaging 63.2% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q3 2024 (growth of 343.4%), and the weakest in Q4 2025 (a decline of 85.0%).
- Business Quant data shows URGN's Short-term Investments at $30.31 million (Q1 2026), $9.71 million (Q4 2025) and $36.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | UroGen Pharma | 2.02 Bn | 1.53 Bn | 65.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 28.84 Mn |
| Mar 31, 2026 | 30.31 Mn |
| Dec 31, 2025 | 9.71 Mn |
| Sep 30, 2025 | 36.99 Mn |
| Jun 30, 2025 | 64.05 Mn |
| Mar 31, 2025 | 91.86 Mn |
| Dec 31, 2024 | 64.70 Mn |
| Sep 30, 2024 | 124.66 Mn |
| Jun 30, 2024 | 21.11 Mn |
| Mar 31, 2024 | 32.61 Mn |
| Dec 31, 2023 | 41.97 Mn |
| Sep 30, 2023 | 28.11 Mn |
| Jun 30, 2023 | 27.17 Mn |
| Mar 31, 2023 | 28.51 Mn |
| Dec 31, 2022 | 44.56 Mn |
| Sep 30, 2022 | 67.23 Mn |
| Jun 30, 2022 | 31.05 Mn |
| Mar 31, 2022 | 31.07 Mn |
| Dec 31, 2021 | 44.78 Mn |
| Sep 30, 2021 | 50.87 Mn |
API Access
UroGen Pharma Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=URGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "URGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=URGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();